Ablynx Competitors and Similar CompaniesClear all
Ablynx's competitors and similar companies include Genfit.
 Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. |  Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. | |
Founding Date | Founding Date 2001 | Founding Date 1999 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Gent, BE HQ | Locations Loos, FR HQ Cambridge, US |
Employees | Employees 1252% decrease | Employees 180 |
Financial | ||
Revenue (est.) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) €65.4m (FY, 2025) |
Net income | Net income (€1.1m) (FY, 2016) | Net income (€86m) (FY, 2025) |
Operating ⚠ | ||
Patents (Foreign) | Patents (Foreign) 180 (Q2, 2017) | Patents (Foreign) 450 (FY, 2019) |
Patents (US) | Patents (US) 50 (Q2, 2017) | Patents (US) 28 (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Genfit
HQ
Loos, FR
Employees
180
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
View company